SAFETY AND EFFICACY OF EXISULIND FOR TREATMENT OF RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
Erik T. Goluboff(Albert Einstein College of Medicine), Carl A. Olsson(United States Department of Veterans Affairs), Alan W. Partin(Johns Hopkins University), Israel Barken(Johns Hopkins University), Bruce J. Giantonio(Northwestern University), I. Bernard Weinstein(University of Helsinki), Daniel B. Rukstalis(University of Miami Hospital), Diane Prager(Johns Hopkins University), MARTIN MADORSKY(Johns Hopkins University)
Cited by 77
Related Papers
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
|Nature Medicine|2019|521
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
|Clinical Cancer Research|2021|358